Review
Aug 2026
HMGB1 signalling in Alzheimer's disease: pathogenic roles and therapeutic prospects.
High mobility group box 1 (HMGB1) is a crucial modulator of neuroinflammation in AD, according to new research, and a viable treatment approach for reducing neuroinflammation and associated pathologies with AD is to target HMGB1-mediated signalling networks.
Prashant Tyagi, Sneha Kumari, Prajjwal Sharma et al.
· International Immunopharmaco... · 1 citation